메뉴 건너뛰기




Volumn 180, Issue 1, 2013, Pages 97-103

Kras mutations and p53 overexpression in pseudomyxoma peritonei: Association with phenotype and prognosis

Author keywords

Appendix; Kras; p53; Prognosis; Pseudomyxoma peritonei

Indexed keywords

K RAS PROTEIN; PROTEIN P53;

EID: 84873729543     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.10.053     Document Type: Article
Times cited : (52)

References (60)
  • 1
    • 38149072411 scopus 로고    scopus 로고
    • Appendiceal neoplasms and pseudomyxoma peritonei: A population based study
    • R.M. Smeenk, M.L. van Velthuysen, and V.J. Verwaal Appendiceal neoplasms and pseudomyxoma peritonei: a population based study Eur J Surg Oncol 34 2008 196
    • (2008) Eur J Surg Oncol , vol.34 , pp. 196
    • Smeenk, R.M.1    Van Velthuysen, M.L.2    Verwaal, V.J.3
  • 2
    • 0028285287 scopus 로고
    • Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors
    • R.A. Prayson, W.R. Hart, and R.E. Petras Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors Am J Surg Pathol 18 1994 591
    • (1994) Am J Surg Pathol , vol.18 , pp. 591
    • Prayson, R.A.1    Hart, W.R.2    Petras, R.E.3
  • 3
    • 0033058535 scopus 로고    scopus 로고
    • Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women
    • C. Szych, A. Staebler, and D.C. Connolly Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women Am J Pathol 154 1999 1849
    • (1999) Am J Pathol , vol.154 , pp. 1849
    • Szych, C.1    Staebler, A.2    Connolly, D.C.3
  • 4
    • 0028822980 scopus 로고
    • Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei."
    • B.M. Ronnett, C.M. Zahn, and R.J. Kurman Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei." Am J Surg Pathol 19 1995 1390
    • (1995) Am J Surg Pathol , vol.19 , pp. 1390
    • Ronnett, B.M.1    Zahn, C.M.2    Kurman, R.J.3
  • 6
    • 33745012931 scopus 로고    scopus 로고
    • Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review
    • R.F. Bradley, J.H. Stewart IV, and G.B. Russell Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review Am J Surg Pathol 30 2006 551
    • (2006) Am J Surg Pathol , vol.30 , pp. 551
    • Bradley, R.F.1    Stewart, I.V.J.H.2    Russell, G.B.3
  • 7
    • 33645858560 scopus 로고    scopus 로고
    • Appendiceal neoplasms with peritoneal dissemination: Outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy
    • J.H. Stewart IV, P. Shen, and G.B. Russell Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy Ann Surg Oncol 13 2006 624
    • (2006) Ann Surg Oncol , vol.13 , pp. 624
    • Stewart, I.V.J.H.1    Shen, P.2    Russell, G.B.3
  • 8
    • 42649145667 scopus 로고    scopus 로고
    • Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
    • R.G. Amado, M. Wolf, and M. Peeters Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer J Clin Oncol 26 2008 1626
    • (2008) J Clin Oncol , vol.26 , pp. 1626
    • Amado, R.G.1    Wolf, M.2    Peeters, M.3
  • 9
    • 59949102930 scopus 로고    scopus 로고
    • A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer
    • J.R. Hecht, E. Mitchell, and T. Chidiac A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer J Clin Oncol 27 2009 672
    • (2009) J Clin Oncol , vol.27 , pp. 672
    • Hecht, J.R.1    Mitchell, E.2    Chidiac, T.3
  • 10
    • 73349114941 scopus 로고    scopus 로고
    • KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: Results from the MRC FOCUS trial
    • S.D. Richman, M.T. Seymour, and P. Chambers KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial J Clin Oncol 27 2009 5931
    • (2009) J Clin Oncol , vol.27 , pp. 5931
    • Richman, S.D.1    Seymour, M.T.2    Chambers, P.3
  • 11
    • 40149088765 scopus 로고    scopus 로고
    • KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
    • W. De Roock, H. Piessevaux, and J. De Schutter KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab Ann Oncol 19 2008 508
    • (2008) Ann Oncol , vol.19 , pp. 508
    • De Roock, W.1    Piessevaux, H.2    De Schutter, J.3
  • 12
    • 77149163487 scopus 로고    scopus 로고
    • KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases
    • G.M. Nash, M. Gimbel, and J. Shia KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases Ann Surg Oncol 17 2010 572
    • (2010) Ann Surg Oncol , vol.17 , pp. 572
    • Nash, G.M.1    Gimbel, M.2    Shia, J.3
  • 14
    • 0024387728 scopus 로고
    • Mutations in the p53 gene occur in diverse human tumour types
    • J.M. Nigro, S.J. Baker, and A.C. Preisinger Mutations in the p53 gene occur in diverse human tumour types Nature 342 1989 705
    • (1989) Nature , vol.342 , pp. 705
    • Nigro, J.M.1    Baker, S.J.2    Preisinger, A.C.3
  • 15
    • 77149176231 scopus 로고    scopus 로고
    • KRAS mutation and microsatellite instability: Two genetic markers of early tumor development that influence the prognosis of colorectal cancer
    • G.M. Nash, M. Gimbel, and A.M. Cohen KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer Ann Surg Oncol 17 2010 416
    • (2010) Ann Surg Oncol , vol.17 , pp. 416
    • Nash, G.M.1    Gimbel, M.2    Cohen, A.M.3
  • 16
    • 0035444798 scopus 로고    scopus 로고
    • Kirsten ras mutations in patients with colorectal cancer: The "rASCAL II" study
    • H.J. Andreyev, A.R. Norman, and D. Cunningham Kirsten ras mutations in patients with colorectal cancer: the "RASCAL II" study Br J Cancer 85 2001 692
    • (2001) Br J Cancer , vol.85 , pp. 692
    • Andreyev, H.J.1    Norman, A.R.2    Cunningham, D.3
  • 17
    • 0032521205 scopus 로고    scopus 로고
    • Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A southwest oncology group study
    • D.J. Ahnen, P. Feigl, and G. Quan Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a southwest oncology group study Cancer Res 58 1998 1149
    • (1998) Cancer Res , vol.58 , pp. 1149
    • Ahnen, D.J.1    Feigl, P.2    Quan, G.3
  • 18
    • 80053137430 scopus 로고    scopus 로고
    • Expression of p53 and DR5 in normal and malignant tissues of colorectal cancer: Correlation with advanced stages
    • A. Perraud, H. Akil, and M. Nouaille Expression of p53 and DR5 in normal and malignant tissues of colorectal cancer: correlation with advanced stages Oncol Rep 26 2011 1091
    • (2011) Oncol Rep , vol.26 , pp. 1091
    • Perraud, A.1    Akil, H.2    Nouaille, M.3
  • 19
    • 0026784607 scopus 로고
    • Increased p53 protein content of colorectal tumours correlates with poor survival
    • Y. Remvikos, O. Tominaga, and P. Hammel Increased p53 protein content of colorectal tumours correlates with poor survival Br J Cancer 66 1992 758
    • (1992) Br J Cancer , vol.66 , pp. 758
    • Remvikos, Y.1    Tominaga, O.2    Hammel, P.3
  • 20
    • 0026453217 scopus 로고
    • Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
    • X.F. Sun, J.M. Carstensen, and H. Zhang Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma Lancet 340 1992 1369
    • (1992) Lancet , vol.340 , pp. 1369
    • Sun, X.F.1    Carstensen, J.M.2    Zhang, H.3
  • 21
    • 0028088897 scopus 로고
    • Association of p53 mutations with short survival in colorectal cancer
    • R. Hamelin, P. Laurent-Puig, and S. Olschwang Association of p53 mutations with short survival in colorectal cancer Gastroenterology 106 1994 42
    • (1994) Gastroenterology , vol.106 , pp. 42
    • Hamelin, R.1    Laurent-Puig, P.2    Olschwang, S.3
  • 22
    • 78149239622 scopus 로고    scopus 로고
    • Expression of p16, p53, and ki-67 in colorectal adenocarcinoma: A study of 356 surgically resected cases
    • J.W. Huh, J.H. Lee, and H.R. Kim Expression of p16, p53, and ki-67 in colorectal adenocarcinoma: a study of 356 surgically resected cases Hepatogastroenterology 57 2010 734
    • (2010) Hepatogastroenterology , vol.57 , pp. 734
    • Huh, J.W.1    Lee, J.H.2    Kim, H.R.3
  • 23
    • 3242731490 scopus 로고    scopus 로고
    • Pseudomyxoma peritonei usually originates from the appendix: A review of the evidence
    • A. Mukherjee, A. Parvaiz, and T.D. Cecil Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence Eur J Gynaecol Oncol 25 2004 411
    • (2004) Eur J Gynaecol Oncol , vol.25 , pp. 411
    • Mukherjee, A.1    Parvaiz, A.2    Cecil, T.D.3
  • 24
    • 84873737142 scopus 로고
    • The organs of digestion
    • R. Warwick, L. Williams, Longman Group Ltd Edinburgh
    • H. Gray The organs of digestion R. Warwick, L. Williams, Gray's anatomy 1973 Longman Group Ltd Edinburgh 173
    • (1973) Gray's Anatomy , pp. 173
    • Gray, H.1
  • 25
    • 0036089446 scopus 로고    scopus 로고
    • Mucinous and nonmucinous appendiceal adenocarcinomas: Different clinicopathological features but similar genetic alterations
    • W. Kabbani, P.S. Houlihan, and R. Luthra Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations Mod Pathol 15 2002 599
    • (2002) Mod Pathol , vol.15 , pp. 599
    • Kabbani, W.1    Houlihan, P.S.2    Luthra, R.3
  • 26
    • 84862576399 scopus 로고    scopus 로고
    • Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms
    • F. Austin, A. Mavanur, and M. Sathaiah Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms Ann Surg Onco 19 2012 1386
    • (2012) Ann Surg Onco , vol.19 , pp. 1386
    • Austin, F.1    Mavanur, A.2    Sathaiah, M.3
  • 27
    • 0032490124 scopus 로고    scopus 로고
    • Kirsten ras mutations in patients with colorectal cancer: The multicenter "rASCAL" study
    • H.J. Andreyev, A.R. Norman, and D. Cunningham Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study J Natl Cancer Inst 90 1998 675
    • (1998) J Natl Cancer Inst , vol.90 , pp. 675
    • Andreyev, H.J.1    Norman, A.R.2    Cunningham, D.3
  • 28
    • 0023748414 scopus 로고
    • Genetic alterations during colorectal-tumor development
    • B. Vogelstein, E.R. Fearon, and S.R. Hamilton Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525
    • (1988) N Engl J Med , vol.319 , pp. 525
    • Vogelstein, B.1    Fearon, E.R.2    Hamilton, S.R.3
  • 29
    • 0023256456 scopus 로고
    • Prevalence of ras gene mutations in human colorectal cancers
    • J.L. Bos, E.R. Fearon, and S.R. Hamilton Prevalence of ras gene mutations in human colorectal cancers Nature 327 1987 293
    • (1987) Nature , vol.327 , pp. 293
    • Bos, J.L.1    Fearon, E.R.2    Hamilton, S.R.3
  • 30
    • 0033021390 scopus 로고    scopus 로고
    • Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas
    • A. Rashid, M. Zahurak, and S.N. Goodman Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas Gut 44 1999 826
    • (1999) Gut , vol.44 , pp. 826
    • Rashid, A.1    Zahurak, M.2    Goodman, S.N.3
  • 31
    • 0027314226 scopus 로고
    • P53 expression and K-ras mutation in colorectal adenomas
    • N. Scott, S.M. Bell, and P. Sagar p53 expression and K-ras mutation in colorectal adenomas Gut 34 1993 621
    • (1993) Gut , vol.34 , pp. 621
    • Scott, N.1    Bell, S.M.2    Sagar, P.3
  • 32
    • 0036142361 scopus 로고    scopus 로고
    • Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas
    • S. Hosaka, Y. Aoki, and T. Akamatsu Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas Cancer 94 2002 219
    • (2002) Cancer , vol.94 , pp. 219
    • Hosaka, S.1    Aoki, Y.2    Akamatsu, T.3
  • 33
    • 0028151812 scopus 로고
    • Immunohistochemical analysis of p53 overexpression in human colonic tumors
    • E. Darmon, K.R. Cleary, and M.J. Wargovich Immunohistochemical analysis of p53 overexpression in human colonic tumors Cancer Detect Prev 18 1994 187
    • (1994) Cancer Detect Prev , vol.18 , pp. 187
    • Darmon, E.1    Cleary, K.R.2    Wargovich, M.J.3
  • 34
    • 0024538344 scopus 로고
    • Expression of the nuclear oncogene p53 in colon tumours
    • F.M. van den Berg, A.J. Tigges, and M.E. Schipper Expression of the nuclear oncogene p53 in colon tumours J Pathol 157 1989 193
    • (1989) J Pathol , vol.157 , pp. 193
    • Van Den Berg, F.M.1    Tigges, A.J.2    Schipper, M.E.3
  • 35
    • 0026040390 scopus 로고
    • Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas
    • E. Campo, O. de la Calle-Martin, and R. Miquel Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas Cancer Res 51 1991 4436
    • (1991) Cancer Res , vol.51 , pp. 4436
    • Campo, E.1    De La Calle-Martin, O.2    Miquel, R.3
  • 36
    • 0032733804 scopus 로고    scopus 로고
    • Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids
    • H. Paraskevakou, A. Saetta, and K. Skandalis Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids Pathol Oncol Res 5 1999 205
    • (1999) Pathol Oncol Res , vol.5 , pp. 205
    • Paraskevakou, H.1    Saetta, A.2    Skandalis, K.3
  • 37
    • 0028956766 scopus 로고
    • Absence of overexpression of p53 protein by intestinal carcinoid tumours
    • G. O'Dowd, and J.R. Gosney Absence of overexpression of p53 protein by intestinal carcinoid tumours J Pathol 175 1995 403
    • (1995) J Pathol , vol.175 , pp. 403
    • O'Dowd, G.1    Gosney, J.R.2
  • 38
    • 77953688634 scopus 로고    scopus 로고
    • Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis
    • I. Zlobec, M.P. Bihl, and H. Schwarb Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis Int J Cancer 127 2010 367
    • (2010) Int J Cancer , vol.127 , pp. 367
    • Zlobec, I.1    Bihl, M.P.2    Schwarb, H.3
  • 39
    • 38449098463 scopus 로고    scopus 로고
    • The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas
    • S. Gurzu, J. Jung, and T. Mezei The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas Rom J Morphol Embryol 48 2007 95
    • (2007) Rom J Morphol Embryol , vol.48 , pp. 95
    • Gurzu, S.1    Jung, J.2    Mezei, T.3
  • 40
    • 32844456752 scopus 로고    scopus 로고
    • Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component
    • S. Ogino, M. Brahmandam, and M. Cantor Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component Mod Pathol 19 2006 59
    • (2006) Mod Pathol , vol.19 , pp. 59
    • Ogino, S.1    Brahmandam, M.2    Cantor, M.3
  • 41
    • 0033141887 scopus 로고    scopus 로고
    • Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum
    • H. Zhang, S. Evertsson, and X. Sun Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum Int J Oncol 14 1999 1057
    • (1999) Int J Oncol , vol.14 , pp. 1057
    • Zhang, H.1    Evertsson, S.2    Sun, X.3
  • 42
    • 0032401026 scopus 로고    scopus 로고
    • K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa
    • H. Zhang, B. Nordenskjold, and M. Dufmats K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa Eur J Cancer 34 1998 2053
    • (1998) Eur J Cancer , vol.34 , pp. 2053
    • Zhang, H.1    Nordenskjold, B.2    Dufmats, M.3
  • 44
    • 0036739336 scopus 로고    scopus 로고
    • Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
    • V. Bazan, M. Migliavacca, and I. Zanna Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype Ann Oncol 13 2002 1438
    • (2002) Ann Oncol , vol.13 , pp. 1438
    • Bazan, V.1    Migliavacca, M.2    Zanna, I.3
  • 45
    • 55349094312 scopus 로고    scopus 로고
    • Etiologic insights from surface adjustment of colorectal carcinoma incidences: An analysis of the U.S. SEER data 2000-2004
    • A. Stang, and A. Kluttig Etiologic insights from surface adjustment of colorectal carcinoma incidences: an analysis of the U.S. SEER data 2000-2004 Am J Gastroenterol 103 2008 2853
    • (2008) Am J Gastroenterol , vol.103 , pp. 2853
    • Stang, A.1    Kluttig, A.2
  • 46
    • 33645468273 scopus 로고    scopus 로고
    • Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: Implications for screening
    • A.L. Zisman, A. Nickolov, and R.E. Brand Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening Arch Intern Med 166 2006 629
    • (2006) Arch Intern Med , vol.166 , pp. 629
    • Zisman, A.L.1    Nickolov, A.2    Brand, R.E.3
  • 47
    • 33748032054 scopus 로고    scopus 로고
    • Associations of ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics
    • J.G. Einspahr, M.E. Martinez, and R. Jiang Associations of ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics Cancer Epidemiol Biomarkers Prev 15 2006 1443
    • (2006) Cancer Epidemiol Biomarkers Prev , vol.15 , pp. 1443
    • Einspahr, J.G.1    Martinez, M.E.2    Jiang, R.3
  • 48
    • 79954476347 scopus 로고    scopus 로고
    • Site impact on colorectal cancer biological behavior in terms of clinicopathological and molecular features
    • P.C. Papagiorgis, A.E. Zizi, and S. Tseleni Site impact on colorectal cancer biological behavior in terms of clinicopathological and molecular features J BUON 16 2011 84
    • (2011) J BUON , vol.16 , pp. 84
    • Papagiorgis, P.C.1    Zizi, A.E.2    Tseleni, S.3
  • 49
    • 34547595713 scopus 로고    scopus 로고
    • Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: Is mucinous carcinoma a distinct histological entity?
    • E. Tozawa, Y. Ajioka, and H. Watanabe Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity? Pathol Res Pract 203 2007 567
    • (2007) Pathol Res Pract , vol.203 , pp. 567
    • Tozawa, E.1    Ajioka, Y.2    Watanabe, H.3
  • 50
    • 34347352268 scopus 로고    scopus 로고
    • Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma
    • C.V. Georgescu, A. Saftoiu, and C.C. Georgescu Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma J Gastrointestin Liver Dis 16 2007 133
    • (2007) J Gastrointestin Liver Dis , vol.16 , pp. 133
    • Georgescu, C.V.1    Saftoiu, A.2    Georgescu, C.C.3
  • 51
    • 21244462418 scopus 로고    scopus 로고
    • A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum
    • H. Kang, J.B. O'Connell, and M.A. Maggard A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum Dis Colon Rectum 48 2005 1161
    • (2005) Dis Colon Rectum , vol.48 , pp. 1161
    • Kang, H.1    O'Connell, J.B.2    Maggard, M.A.3
  • 52
    • 0141456482 scopus 로고    scopus 로고
    • Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma
    • I.I. Wistuba, C. Behrens, and J. Albores-Saavedra Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma Clin Cancer Res 9 2003 3615
    • (2003) Clin Cancer Res , vol.9 , pp. 3615
    • Wistuba, I.I.1    Behrens, C.2    Albores-Saavedra, J.3
  • 53
    • 0033168411 scopus 로고    scopus 로고
    • K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix
    • D.M. Ramnani, I.I. Wistuba, and C. Behrens K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix Cancer 86 1999 14
    • (1999) Cancer , vol.86 , pp. 14
    • Ramnani, D.M.1    Wistuba, I.I.2    Behrens, C.3
  • 54
    • 79952392909 scopus 로고    scopus 로고
    • Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
    • C.P. Vaughn, S.D. Zobell, and L.V. Furtado Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer Genes Chromosomes Cancer 50 2011 307
    • (2011) Genes Chromosomes Cancer , vol.50 , pp. 307
    • Vaughn, C.P.1    Zobell, S.D.2    Furtado, L.V.3
  • 55
    • 0033739215 scopus 로고    scopus 로고
    • Relationship of ki-ras mutations in colon cancers to tumor location, stage, and survival: A population-based study
    • W.S. Samowitz, K. Curtin, and D. Schaffer Relationship of ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study Cancer Epidemiol Biomarkers Prev 9 2000 1193
    • (2000) Cancer Epidemiol Biomarkers Prev , vol.9 , pp. 1193
    • Samowitz, W.S.1    Curtin, K.2    Schaffer, D.3
  • 56
    • 77956602320 scopus 로고    scopus 로고
    • KRAS status in patients with colorectal cancer peritoneal carcinomatosis and its impact on outcome
    • S.M. Gillern, T.C. Chua, and A. Stojadinovic KRAS status in patients with colorectal cancer peritoneal carcinomatosis and its impact on outcome Am J Clin Oncol 33 2010 456
    • (2010) Am J Clin Oncol , vol.33 , pp. 456
    • Gillern, S.M.1    Chua, T.C.2    Stojadinovic, A.3
  • 57
    • 23944488225 scopus 로고    scopus 로고
    • The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
    • A. Conlin, G. Smith, and F.A. Carey The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma Gut 54 2005 1283
    • (2005) Gut , vol.54 , pp. 1283
    • Conlin, A.1    Smith, G.2    Carey, F.A.3
  • 58
    • 68249087325 scopus 로고    scopus 로고
    • Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: A special reference to classification and predictive factors
    • S.O. Yoon, B.H. Kim, and H.S. Lee Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors Mod Pathol 22 2009 1102
    • (2009) Mod Pathol , vol.22 , pp. 1102
    • Yoon, S.O.1    Kim, B.H.2    Lee, H.S.3
  • 59
    • 79956212595 scopus 로고    scopus 로고
    • Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: An evaluation of 46 consecutive patients
    • T.C. Chua, I. Al-Alem, and A. Saxena Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients Ann Surg Oncol 18 2011 1540
    • (2011) Ann Surg Oncol , vol.18 , pp. 1540
    • Chua, T.C.1    Al-Alem, I.2    Saxena, A.3
  • 60
    • 84856675754 scopus 로고    scopus 로고
    • The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis
    • H. El Halabi, V. Gushchin, and J. Francis The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis Ann Surg Oncol 19 2012 110
    • (2012) Ann Surg Oncol , vol.19 , pp. 110
    • El Halabi, H.1    Gushchin, V.2    Francis, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.